Skip to main content

achieved goals


In 2021, the 2nd funding year within the RECORD program of the Else Kröner-Fresenius-Foundation (EKFS), which was approved for a total of 3 years, came to an end.

The project is led by Prof. Dr. med. Mario Schiffer, the Clinic Director of the Medical Clinic 4 of the University Hospital Erlangen. The University Medical Center Hamburg Eppendorf as well as the University Medical Center Cologne participate in the research college as project partners. RECORD offers young physicians a career development structure in the field of research and clinical care of patients with rare kidney diseases. Researchers are encouraged to participate in external congresses, network meetings, and locally organized guest speaker seminars. In addition, participants are expected to attend all structured modules of the local Clinician Scientist programs, all aimed at introducing young clinicians to academic work. Here, RECORD participants will be accompanied by the clinical scientist modules of the interdisciplinary Center for Clinical Research (IZKF) Erlangen.

As in the 1st year of the funding period, several residents of the University Hospital Erlangen were able to be released from their medical duties and successfully conduct research on rare kidney diseases within the framework of the program in 2021.


Other goals achieved:

  • The largest cross-sectional study to date of sensor-based gait analysis in 112 HSP patients and 112 matched control subjects was published in the journal NEUROLOGY (impact factor 9.9)
  • Establishment as SMA screening center (DGM-certified) and gene therapy center
  • Establishment of a cross-age CF center
  • Establishment of a urinary stone center for children
  • In November 2021, the Center for Ectodermal Dysplasias started a multicenter, international phase 2 study on prenatal therapy of X-linked hypohidrotic ectodermal dysplasia, which had been prepared for years.